Vorinostat in Treating Patients With Metastatic Melanoma of the Eye

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01587352
Recruitment Status : Suspended (Other - Non-compliance with sponsor data reporting requirements)
First Posted : April 30, 2012
Last Update Posted : November 21, 2017
Institut Curie Paris
Memorial Sloan Kettering Cancer Center
Moffitt Cancer Center P2C
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : November 20, 2017
  Study Completion Date : No date given